Bio*One takes US$10m stake in Nasdaq firm



SINGAPORE biomedical investment firm Bio*One Capital has pumped US$10 million into Alexza Pharmaceuticals in a deal that involves the Nasdaq-listed company setting up a manufacturing plant here.